Advertisement
Advertisement
ATNM
Actinium Pharmaceuticals, Inc
1.43
USDSponsored
+0.13
+10.00%
Nov 06, 15:59 UTC -5
Closed
After-Market
1.44
+0.01
+0.49%
Actinium Pharmaceuticals, Inc (ATNM)
Actinium Pharmaceuticals, Inc Financial Snapshot
| Market Cap | 45.18M |
| Beta | 0.27 |
| Earnings Per Share (EPS) | 0.36 |
| Price-to-Book (P/B) Ratio | 1.48 |
| Operating Margin | -- |
| Total Debt/Equity (D/E) | 0.02% |
| P/E Ratio | 3.97 |
| Return on Equity (ROE) | 83.42% |
| Current Ratio | 4.08% |
| Free Cash Flow | -11.53M |
